ISO 21649:2023

Overview

ISO 21649:2023 - "Needle-free injection systems for medical use - Requirements and test methods" - is an international standard that specifies safety, performance and testing requirements for single‑use and multiple‑use Needle‑Free Injection Systems (NFISs) intended for human clinical and personal use. This second edition (2023) updates the original 2006 edition and focuses on a risk‑based approach to specifications and testing while enabling design flexibility and innovation for NFIS manufacturers.

Key scope points:

• Covers NFIS devices where the dose chamber may be disposable (cartridge/ampoule/syringe) or permanent with cross‑contamination controls.
• Excludes needle‑penetrating devices, aerosol/inhalation systems, transdermal patches, sonic/electromagnetic delivery, and infusion/ catheter systems.

Key topics and requirements

ISO 21649 defines performance expectations and test methods rather than prescribing detailed construction, with emphasis on:

• Dose accuracy and methods to verify delivered volume/accuracy.
• Usability engineering (human factors) to reduce user error in clinics and self‑administration.
• Risk management approach to justify deviations, substitutions or product‑specific requirements.
• Environmental and robustness testing (preconditioning and in‑use): standard/cool/hot atmospheres, damp heat, dry heat, cold, cyclical testing, transport, vibration, shock and free‑fall.
• Electromagnetic compatibility (EMC) for NFISs with electrical components.
• Noise requirements, water and dust resistance, and inspection/test reporting procedures.
• Auto‑disable / re‑use prevention features and tests to reduce cross‑contamination risk-important for mass vaccination settings.
• Sampling plans to verify lot conformity (complements but does not replace quality system standards).

Applications and who uses it

ISO 21649 is intended for:

• Medical device manufacturers designing and validating NFIS hardware and dose chambers.
• Test laboratories performing environmental, performance and EMC testing.
• Regulatory bodies and notified bodies assessing conformity for market access.
• Procurement and clinical users (hospitals, vaccination programs) evaluating device robustness, infection control and usability.
• Design engineers & quality teams integrating ISO 21649 requirements into product development and risk files.

Practical uses include guiding design decisions on re‑use prevention, establishing test protocols for dose accuracy, and demonstrating device robustness for field or mass‑immunization deployment.

Related standards

• ISO 11608 series (mentioned alignment on approach)
• ISO 13485 and ISO 9001 (quality system context)
• EMC standards (for electrical NFIS components)

Keywords: ISO 21649, needle‑free injection systems, NFIS, medical device testing, dose accuracy, auto‑disable, risk‑based approach, damp heat testing, water and dust resistance, usability engineering.